US5545522A
(en)
|
1989-09-22 |
1996-08-13 |
Van Gelder; Russell N. |
Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
|
US7049102B1
(en)
|
1989-09-22 |
2006-05-23 |
Board Of Trustees Of Leland Stanford University |
Multi-gene expression profile
|
US5744300A
(en)
*
|
1993-03-24 |
1998-04-28 |
Geron Corporation |
Methods and reagents for the identification and regulation of senescence-related genes
|
US5580726A
(en)
*
|
1994-04-29 |
1996-12-03 |
Geron Corporation |
Method and Kit for enhanced differential display
|
DE4317414C1
(de)
*
|
1993-05-18 |
1994-04-21 |
Max Planck Gesellschaft |
Mittel zur komplexen Diagnostik der Genexpression und Verfahren zur Anwendung für die medizinische Diagnostik und die Genisolierung
|
US5889159A
(en)
*
|
1993-10-29 |
1999-03-30 |
Dana-Farber Cancer Institute, Inc. |
Monoclonal antibodies to tumor marker TC1 and methods for use of same
|
US5459037A
(en)
*
|
1993-11-12 |
1995-10-17 |
The Scripps Research Institute |
Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
|
US6110680A
(en)
*
|
1993-11-12 |
2000-08-29 |
The Scripps Research Institute |
Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
|
US6096503A
(en)
*
|
1993-11-12 |
2000-08-01 |
The Scripps Research Institute |
Method for simultaneous identification of differentially expresses mRNAs and measurement of relative concentrations
|
US6986985B1
(en)
*
|
1994-01-13 |
2006-01-17 |
Enzo Life Sciences, Inc. |
Process for producing multiple nucleic acid copies in vivo using a protein-nucleic acid construct
|
US20110097791A1
(en)
*
|
1999-04-16 |
2011-04-28 |
Engelhardt Dean L |
Novel process, construct and conjugate for producing multiple nucleic acid copies
|
US20050123926A1
(en)
*
|
1994-01-13 |
2005-06-09 |
Enzo Diagnostics, Inc., |
In vitro process for producing multiple nucleic acid copies
|
US6379897B1
(en)
*
|
2000-11-09 |
2002-04-30 |
Nanogen, Inc. |
Methods for gene expression monitoring on electronic microarrays
|
RU2111254C1
(ru)
*
|
1994-07-11 |
1998-05-20 |
Институт молекулярной биологии им.В.А.Энгельгардта РАН |
СПОСОБ ДЕТЕКЦИИ ДИФФЕРЕНЦИАЛЬНО ЭКСПРЕССИРУЮЩИХСЯ МАТРИЧНЫХ РНК И КЛОНИРОВАНИЯ СООТВЕТСТВУЮЩИХ ИМ ФРАГМЕНТОВ кДНК
|
US5707807A
(en)
*
|
1995-03-28 |
1998-01-13 |
Research Development Corporation Of Japan |
Molecular indexing for expressed gene analysis
|
DE19518505A1
(de)
*
|
1995-05-19 |
1996-11-21 |
Max Planck Gesellschaft |
Verfahren zur Genexpressionsanalyse
|
US7094766B1
(en)
|
1995-06-06 |
2006-08-22 |
Trustees Of Boston University |
Use of locally applied DNA fragments
|
US6147056A
(en)
*
|
1995-06-06 |
2000-11-14 |
Trustees Of Boston University |
Use of locally applied DNA fragments
|
WO2001074342A2
(en)
*
|
2000-03-31 |
2001-10-11 |
Trustees Of Boston University |
Use of locally applied dna fragments
|
US20030032610A1
(en)
*
|
1996-06-03 |
2003-02-13 |
Gilchrest Barbara A. |
Method to inhibit cell growth using oligonucleotides
|
US6218529B1
(en)
*
|
1995-07-31 |
2001-04-17 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
|
CA2262403C
(en)
*
|
1995-07-31 |
2011-09-20 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate disease
|
AU2264197A
(en)
*
|
1996-02-09 |
1997-08-28 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Restriction display (rd-pcr) of differentially expressed mrnas
|
AU2447597A
(en)
*
|
1996-04-03 |
1997-10-22 |
Johnson & Johnson Consumer Products, Inc. |
Improved technique for differential display
|
US5776683A
(en)
*
|
1996-07-11 |
1998-07-07 |
California Pacific Medical Center |
Methods for identifying genes amplified in cancer cells
|
JPH1094396A
(ja)
*
|
1996-06-06 |
1998-04-14 |
Smithkline Beecham Corp |
ランダムにプライムされた増幅を用いてヌクレオチド配列を取得する方法
|
WO1998002575A1
(en)
*
|
1996-07-16 |
1998-01-22 |
Periannan Senapathy |
Method for contiguous genome sequencing
|
JPH1057064A
(ja)
*
|
1996-08-16 |
1998-03-03 |
Rikagaku Kenkyusho |
微量遺伝子産物の特異的増幅方法
|
EP1007730A4
(de)
|
1996-08-30 |
2004-04-28 |
Invitrogen Corp |
Verfahren zur identifizierung und isolierung von spezifischen nukleotidsequenzen in cdna und genomischer dna
|
US20040142327A1
(en)
*
|
1996-11-22 |
2004-07-22 |
Jhy-Jhu Lin |
Methods for identifying and isolating DNA polymorphisms or genetic markers
|
US6306588B1
(en)
*
|
1997-02-07 |
2001-10-23 |
Invitrogen Corporation |
Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
|
AU6444698A
(en)
*
|
1997-03-03 |
1998-09-22 |
Tariq M. HAQQI |
Methods and compositions for identifying expressed genes
|
US6162616A
(en)
*
|
1997-04-16 |
2000-12-19 |
Millennium Pharmaceuticals, Inc. |
Multidrug resistance-associated polypeptide
|
AU7265298A
(en)
*
|
1997-04-29 |
1998-11-24 |
Trustees Of Boston University |
Methods and compositions for targeted dna differential display
|
EP0979282A1
(de)
*
|
1997-04-30 |
2000-02-16 |
F. Hoffmann-La Roche Ag |
Rattenchemonikin st38.2
|
US6261770B1
(en)
|
1997-05-13 |
2001-07-17 |
Display Systems Biotech Aps |
Method to clone mRNAs
|
DE69801749T2
(de)
*
|
1997-05-13 |
2002-07-04 |
Azign Bioscience As Kopenhagen |
Eine methode zum klonieren von mrna und darstellung von differentiell exprimierten transcripten (dodet)
|
US5994076A
(en)
*
|
1997-05-21 |
1999-11-30 |
Clontech Laboratories, Inc. |
Methods of assaying differential expression
|
US6489455B2
(en)
|
1997-05-21 |
2002-12-03 |
Clontech Laboratories, Inc. |
Methods of assaying differential expression
|
EP1007739A2
(de)
*
|
1997-09-05 |
2000-06-14 |
Sidney Kimmel Cancer Center |
Auswahl von pcr primerpaaren zur amplifikation einer gruppe von nukleotidsequenzen
|
US7031843B1
(en)
|
1997-09-23 |
2006-04-18 |
Gene Logic Inc. |
Computer methods and systems for displaying information relating to gene expression data
|
US6150096A
(en)
*
|
1997-09-26 |
2000-11-21 |
Universite De Sherbrooke |
Molecular markers for the diagnosis of human diseases including Crohn's disease
|
US6897066B1
(en)
|
1997-09-26 |
2005-05-24 |
Athersys, Inc. |
Compositions and methods for non-targeted activation of endogenous genes
|
US6277571B1
(en)
|
1997-10-03 |
2001-08-21 |
Virginia Commonwealth University Intellectual Property Foundation |
Sequential consensus region-directed amplification of known and novel members of gene families
|
US6090553A
(en)
*
|
1997-10-29 |
2000-07-18 |
Beckman Coulter, Inc. |
Use of uracil-DNA glycosylase in genetic analysis
|
US6087102A
(en)
|
1998-01-07 |
2000-07-11 |
Clontech Laboratories, Inc. |
Polymeric arrays and methods for their use in binding assays
|
DE19806431C1
(de)
*
|
1998-02-17 |
1999-10-14 |
Novartis Ag |
Neues Verfahren zur Identifikation und Charakterisierung von mRNA-Molekülen
|
US6365346B1
(en)
|
1998-02-18 |
2002-04-02 |
Dade Behring Inc. |
Quantitative determination of nucleic acid amplification products
|
WO1999043844A1
(en)
*
|
1998-02-27 |
1999-09-02 |
The Trustees Of Columbia University In The City Of New York |
Reciprocal subtraction differential display
|
US5882874A
(en)
*
|
1998-02-27 |
1999-03-16 |
The Trustees Of Columbia University In The City Of New York |
Reciprocal subtraction differential display
|
US6657053B1
(en)
|
1999-02-26 |
2003-12-02 |
The Trustees Of Columbia University In The City Of New York |
Reciprocal subtraction differential display
|
US6090593A
(en)
*
|
1998-05-13 |
2000-07-18 |
The United States Of America As Represented By The Secretary Of The Air Force |
Isolation of expressed genes in microorganisms
|
DE19840731A1
(de)
|
1998-09-07 |
2000-03-09 |
Hoechst Marion Roussel De Gmbh |
Zwei Farben Differential Display als Verfahren zur Detektion regulierter Gene
|
AU6507099A
(en)
*
|
1998-09-29 |
2000-04-17 |
Arch Development Corporation |
A new strategy for genome-wide gene analysis: integrated procedures for gene identification
|
IL142965A0
(en)
*
|
1998-11-04 |
2002-04-21 |
Digital Gene Tech Inc |
METHOD FOR INDEXING AND DETERMINING THE RELATIVE CONCENTRATION OF EXPRESSED MESSSENGER RNAs
|
AU1724000A
(en)
|
1998-11-12 |
2000-05-29 |
Nyxis, Inc. |
Diagnostic assay for cancer
|
WO2000029621A2
(en)
*
|
1998-11-16 |
2000-05-25 |
Genelabs Technologies, Inc. |
Method for measuring target polynucleotides and novel asthma biomolecules
|
US6156515A
(en)
*
|
1999-02-09 |
2000-12-05 |
Urocor, Inc. |
Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
|
WO2000049162A2
(en)
*
|
1999-02-19 |
2000-08-24 |
Athersys, Inc. |
Compositions and methods for non-targeted activation of endogenous genes
|
AU3919900A
(en)
*
|
1999-03-25 |
2000-10-09 |
University Of Maryland Biotechnology Institute |
Method of differential display of prokaryotic messenger rna by rtpcr
|
US6759195B1
(en)
|
1999-03-25 |
2004-07-06 |
University Of Maryland Biotechnology Institute |
Method of differential display of prokaryotic messenger RNA by RTPCR
|
US6582906B1
(en)
|
1999-04-05 |
2003-06-24 |
Affymetrix, Inc. |
Proportional amplification of nucleic acids
|
WO2000063436A1
(en)
*
|
1999-04-20 |
2000-10-26 |
Joslin Diabetes Center, Inc. |
Disease reversing targets
|
AU5008900A
(en)
*
|
1999-05-12 |
2000-11-21 |
Invitrogen Corporation |
Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
|
US6429357B1
(en)
|
1999-05-14 |
2002-08-06 |
Dekalb Genetics Corp. |
Rice actin 2 promoter and intron and methods for use thereof
|
AU4332399A
(en)
*
|
1999-06-04 |
2000-12-28 |
Cheng-Ming Chuong |
Rna polymerase chain reaction
|
WO2000077024A1
(en)
*
|
1999-06-14 |
2000-12-21 |
New York Blood Center, Inc. |
Camello gene family and uses thereof
|
US6692915B1
(en)
|
1999-07-22 |
2004-02-17 |
Girish N. Nallur |
Sequencing a polynucleotide on a generic chip
|
US6864050B2
(en)
*
|
1999-07-30 |
2005-03-08 |
Affymetrix, Inc. |
Single-phase amplification of nucleic acids
|
US6416956B1
(en)
|
1999-08-13 |
2002-07-09 |
George Washington University |
Transcription factor, BP1
|
US6692918B2
(en)
*
|
1999-09-13 |
2004-02-17 |
Nugen Technologies, Inc. |
Methods and compositions for linear isothermal amplification of polynucleotide sequences
|
CA2398107C
(en)
*
|
2000-01-28 |
2013-11-19 |
Althea Technologies, Inc. |
Methods for analysis of gene expression
|
WO2001071036A2
(en)
*
|
2000-03-17 |
2001-09-27 |
Gene Logic, Inc. |
Methods of preparing amplified nucleic acid molecules
|
US6468749B1
(en)
|
2000-03-30 |
2002-10-22 |
Quark Biotech, Inc. |
Sequence-dependent gene sorting techniques
|
US6387624B1
(en)
|
2000-04-14 |
2002-05-14 |
Incyte Pharmaceuticals, Inc. |
Construction of uni-directionally cloned cDNA libraries from messenger RNA for improved 3′ end DNA sequencing
|
US7846733B2
(en)
|
2000-06-26 |
2010-12-07 |
Nugen Technologies, Inc. |
Methods and compositions for transcription-based nucleic acid amplification
|
WO2002000938A2
(en)
*
|
2000-06-26 |
2002-01-03 |
Nugen Technologies, Inc. |
Methods and compositions for transcription-based nucleic acid amplification
|
JP4340779B2
(ja)
*
|
2000-10-05 |
2009-10-07 |
独立行政法人理化学研究所 |
可変突出部位を含むオリゴヌクレオチドリンカー及び前記リンカーを用いたポリヌクレオチドライブラリーの調製方法
|
DE60141221D1
(de)
*
|
2000-12-12 |
2010-03-18 |
Masumi Abe |
Verfahren zur genexpressionsanalyse
|
WO2002048402A2
(en)
|
2000-12-13 |
2002-06-20 |
Nugen Technologies, Inc. |
Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
|
US6794141B2
(en)
|
2000-12-22 |
2004-09-21 |
Arcturus Bioscience, Inc. |
Nucleic acid amplification
|
ZA200210369B
(en)
|
2001-03-09 |
2004-07-08 |
Nugen Technologies Inc |
Methods and compositions for amplification or RNA sequences.
|
US7094536B2
(en)
*
|
2001-03-09 |
2006-08-22 |
Nugen Technologies, Inc. |
Methods and compositions for amplification of RNA sequences
|
EP1275738A1
(de)
*
|
2001-07-11 |
2003-01-15 |
Roche Diagnostics GmbH |
Verfahren zur zufällige Synthese und Amplifikation komplementäres DNA
|
EP1275734A1
(de)
*
|
2001-07-11 |
2003-01-15 |
Roche Diagnostics GmbH |
Verfahren zur zufällige Synthese und Amplifikation komplementäres DNA
|
US20120077196A9
(en)
*
|
2001-09-03 |
2012-03-29 |
Guido Krupp |
Universal method for selective amplification of mRNAs
|
DE10143106C1
(de)
*
|
2001-09-03 |
2002-10-10 |
Artus Ges Fuer Molekularbiolog |
Vermehrung von Ribonukleinsäuren
|
AU2002360068B2
(en)
*
|
2001-12-21 |
2009-09-03 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Method for cloning of variable domain sequences
|
US7176025B2
(en)
*
|
2002-03-11 |
2007-02-13 |
Nugen Technologies, Inc. |
Methods for generating double stranded DNA comprising a 3′ single stranded portion and uses of these complexes for recombination
|
US20040005614A1
(en)
*
|
2002-05-17 |
2004-01-08 |
Nurith Kurn |
Methods for fragmentation, labeling and immobilization of nucleic acids
|
DE10240868A1
(de)
*
|
2002-09-04 |
2004-03-18 |
Artus Gesellschaft für molekularbiologische Diagnostik und Entwicklung mbH |
Verbesserte Verfahren zur Synthese von Nukleinsäuren
|
US20060269924A1
(en)
*
|
2003-04-11 |
2006-11-30 |
Trustees Of Boston University |
Modulation of telomere-initiated cell signaling
|
WO2004092418A2
(en)
*
|
2003-04-14 |
2004-10-28 |
Nugen Technologies, Inc. |
Global amplification using a randomly primed composite primer
|
EP1711591A4
(de)
*
|
2003-12-29 |
2010-04-28 |
Nugen Technologies Inc |
Verfahren zur analyse des methylierungsstatus von nukleinsäure und verfahren zur fragmentierung, markierung und immobilisierung von nukleinsäuren
|
WO2005070948A1
(en)
|
2004-01-23 |
2005-08-04 |
Intronn, Inc. |
Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated rna trans splicing
|
EP2471921A1
(de)
|
2004-05-28 |
2012-07-04 |
Asuragen, Inc. |
Verfahren und Zusammensetzungen mit microRNA
|
US20090197249A1
(en)
|
2004-11-01 |
2009-08-06 |
George Mason University |
Compositions and methods for diagnosing colon disorders
|
US20090118132A1
(en)
*
|
2004-11-04 |
2009-05-07 |
Roche Molecular Systems, Inc. |
Classification of Acute Myeloid Leukemia
|
EP2302054B1
(de)
|
2004-11-12 |
2014-07-16 |
Asuragen, Inc. |
Verfahren und Zusammensetzungen, die miRNAs und miRNA-inhibitorischen Molekülen verbunden sind
|
CA2621267A1
(en)
|
2005-09-07 |
2007-03-15 |
Nugen Technologies, Inc. |
Improved nucleic acid amplification procedure
|
US7368246B2
(en)
*
|
2005-09-15 |
2008-05-06 |
Primera Biosystems, Inc. |
Quantitative gene expression profiling
|
AT502823B1
(de)
|
2005-11-29 |
2007-06-15 |
Seitz Alexander Dr |
Polynukleotid-amplifikation
|
US7833716B2
(en)
|
2006-06-06 |
2010-11-16 |
Gen-Probe Incorporated |
Tagged oligonucleotides and their use in nucleic acid amplification methods
|
CA2656315A1
(en)
*
|
2006-06-30 |
2008-01-10 |
Nugen Technologies, Inc. |
Methods for fragmentation and labeling of nucleic acids
|
CA2663962A1
(en)
|
2006-09-19 |
2008-03-27 |
Asuragen, Inc. |
Mir-15, mir-26, mir-31,mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
|
WO2008036765A2
(en)
|
2006-09-19 |
2008-03-27 |
Asuragen, Inc. |
Micrornas differentially expressed in pancreatic diseases and uses thereof
|
WO2008079972A2
(en)
|
2006-12-20 |
2008-07-03 |
Bayer Healthcare Llc |
4-{4- [ ({3-tert-butyl-1- [3- (hydroxymethyl) phenyl] - 1h- pyrazol- 5 -yl } carbamoyl) -amin o] -3-chlorophenoxy} -n-methylpyridine-2-carboxamide as an inhibitor of the vegfr kinase for the treatment of cancer
|
US8034568B2
(en)
|
2008-02-12 |
2011-10-11 |
Nugen Technologies, Inc. |
Isothermal nucleic acid amplification methods and compositions
|
GB2470672B
(en)
|
2008-03-21 |
2012-09-12 |
Nugen Technologies Inc |
Methods of RNA amplification in the presence of DNA
|
WO2009137807A2
(en)
|
2008-05-08 |
2009-11-12 |
Asuragen, Inc. |
Compositions and methods related to mirna modulation of neovascularization or angiogenesis
|
US20100240024A1
(en)
*
|
2008-09-03 |
2010-09-23 |
Abbott Laboratories |
Assays And Kits For Determining HIV-1 Tropism
|
US8362318B2
(en)
|
2008-12-18 |
2013-01-29 |
Board Of Trustees Of Michigan State University |
Enzyme directed oil biosynthesis in microalgae
|
US9096895B2
(en)
*
|
2009-02-02 |
2015-08-04 |
Exiqon A/S |
Method for quantification of small RNA species
|
WO2010141928A2
(en)
|
2009-06-05 |
2010-12-09 |
University Of Florida Research Foundation, Inc. |
Isolation and targeted suppression of lignin biosynthetic genes from sugarcane
|
US20110059453A1
(en)
*
|
2009-08-23 |
2011-03-10 |
Affymetrix, Inc. |
Poly(A) Tail Length Measurement by PCR
|
DE102009056729A1
(de)
*
|
2009-12-04 |
2011-06-09 |
Qiagen Gmbh |
Verfahren zum Nachweis und zur Quantifizierung von Poly(A)RNA und mRNA
|
WO2011082253A2
(en)
|
2009-12-30 |
2011-07-07 |
Board Of Trustees Of Michigan State University |
A method to produce acetyldiacylglycerols (ac-tags) by expression ofan acetyltransferase gene isolated from euonymus alatus (burning bush)
|
WO2011108930A1
(en)
|
2010-03-04 |
2011-09-09 |
Interna Technologies Bv |
A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT
|
CN103079567A
(zh)
|
2010-04-17 |
2013-05-01 |
拜尔健康护理有限责任公司 |
用于疾病和病症的治疗和预防的氟取代的ω-羧基芳基二苯脲的合成代谢产物
|
NZ719520A
(en)
|
2010-07-06 |
2017-07-28 |
Int Tech Bv |
Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
|
ES2629890T3
(es)
|
2010-11-17 |
2017-08-16 |
Interpace Diagnostics, Llc |
miARN como biomarcadores para distinguir entre neoplasias de tiroides benignas y malignas
|
CN108744262A
(zh)
|
2010-11-23 |
2018-11-06 |
普莱萨格生命科学公司 |
用于实体递送的治疗方法和组合物
|
EP2474617A1
(de)
|
2011-01-11 |
2012-07-11 |
InteRNA Technologies BV |
MIR zur Behandlung von Neoangiogenese
|
WO2012158238A2
(en)
|
2011-02-28 |
2012-11-22 |
University Of Iowa Research Foundation |
Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender
|
WO2013040251A2
(en)
|
2011-09-13 |
2013-03-21 |
Asurgen, Inc. |
Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
|
EP2769007B1
(de)
|
2011-10-19 |
2016-12-07 |
Nugen Technologies, Inc. |
Zusammensetzungen und verfahren zur direktionalen amplifikation und sequenzierung von nukleinsäuren
|
WO2013063519A1
(en)
|
2011-10-26 |
2013-05-02 |
Asuragen, Inc. |
Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts
|
US20130142728A1
(en)
|
2011-10-27 |
2013-06-06 |
Asuragen, Inc. |
Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
|
US9243037B2
(en)
|
2011-11-10 |
2016-01-26 |
Trustees Of Boston College |
Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity
|
WO2013112923A1
(en)
|
2012-01-26 |
2013-08-01 |
Nugen Technologies, Inc. |
Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
|
CA2877094A1
(en)
|
2012-06-18 |
2013-12-27 |
Nugen Technologies, Inc. |
Compositions and methods for negative selection of non-desired nucleic acid sequences
|
EP2870263A1
(de)
|
2012-07-03 |
2015-05-13 |
InteRNA Technologies B.V. |
Diagnoseportfolio und dessen verwendungen
|
US20150011396A1
(en)
|
2012-07-09 |
2015-01-08 |
Benjamin G. Schroeder |
Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
|
US20140100124A1
(en)
|
2012-10-04 |
2014-04-10 |
Asuragen, Inc. |
Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
|
EP2971132B1
(de)
|
2013-03-15 |
2020-05-06 |
Baylor Research Institute |
Gewebe- und blutbasierte mirna-biomarker zur diagnose, prognose und vorhersage des metastasepotenzials bei kolorektalkrebs
|
EP2970909A4
(de)
|
2013-03-15 |
2017-02-15 |
The University of Chicago |
Verfahren und zusammensetzungen in zusammenhang mit t-zell aktivität
|
WO2014144092A1
(en)
|
2013-03-15 |
2014-09-18 |
Nugen Technologies, Inc. |
Sequential sequencing
|
WO2014151551A1
(en)
|
2013-03-15 |
2014-09-25 |
Baylor Research Institute |
Ulcerative colitis (uc)-associated colorectal neoplasia markers
|
EP3068883B1
(de)
|
2013-11-13 |
2020-04-29 |
Nugen Technologies, Inc. |
Zusammensetzungen und verfahren zur identifizierung einer duplikatsequenzierungslesung
|
US10392629B2
(en)
|
2014-01-17 |
2019-08-27 |
Board Of Trustees Of Michigan State University |
Increased caloric and nutritional content of plant biomass
|
WO2015131107A1
(en)
|
2014-02-28 |
2015-09-03 |
Nugen Technologies, Inc. |
Reduced representation bisulfite sequencing with diversity adaptors
|
US10550440B2
(en)
|
2016-02-26 |
2020-02-04 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Synthetic translation-sensing riboswitches and uses thereof
|
US11099202B2
(en)
|
2017-10-20 |
2021-08-24 |
Tecan Genomics, Inc. |
Reagent delivery system
|
US11497762B2
(en)
|
2017-11-03 |
2022-11-15 |
Interna Technologies B.V. |
MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
|
KR20210151944A
(ko)
|
2019-04-12 |
2021-12-14 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
근육량 및 산화 대사를 증가시키기 위한 조성물 및 방법
|
CN114269946A
(zh)
*
|
2019-08-20 |
2022-04-01 |
国立感染症研究所长 |
核苷酸序列的扩增方法和序列确定方法
|
WO2024028794A1
(en)
|
2022-08-02 |
2024-02-08 |
Temple Therapeutics BV |
Methods for treating endometrial and ovarian hyperproliferative disorders
|